The UK’s Cell and Gene Therapy Catapult enters Japanese collaboration

The Cell and Gene Therapy Catapult (CGT Catapult) has signed a Memorandum of Understanding (MoU) with the Japanese Society for Regenerative Medicine (JSRM) – the largest society for regenerative medicine in the world

The agreement aims to advance regenerative medicine and cell and gene therapies in both the UK and Japan.

JSRM and the CGT Catapult aim to advance their individual and common missions by promoting collaboration to facilitate activities by enterprises and academic institutions of both regions in the field of regenerative medicine and cell and gene therapies.

The organisations will also share information encompassing technologies, policies, legal issues and assist one another in sponsoring and hosting meetings.

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

Related news